Abstract
BackgroundA linear increase in the number of valvular heart disease is expected due to the aging population, yet most patients with severe valvular heart disease remain undiagnosed.HypothesisPOCUS can serve as a screening tool for valvular heart disease.MethodsWe reviewed the literature to assess the strengths and limitations of POCUS in screening and diagnosing valvular heart disease.ResultsPOCUS is an accurate, affordable, accessible, and comprehensive tool. It has a fast learning curve and can prevent unnecessary and more expensive imaging. Challenges include training availability, lack of simplified screening protocols, and reimbursement. Large scale valvular screening data utilizing POCUS is not available.ConclusionPOCUS can serve as a screening tool and guide the management of patients with valvular heart disease. More data is needed about its efficacy and cost‐effectiveness in the screening of patients with valvular heart disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
